Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 88.59%-30.58M | ---- | 29.74%-452.59M | ---- | 37.57%-267.92M | ---- | 27.92%-644.21M | ---- | 3.73%-429.18M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 34.45%-61.98M | ---- | 10.79%-171.59M | ---- | -0.84%-94.56M | ---- | -40.48%-192.33M | ---- | -58.44%-93.77M |
| Investment loss (gain) | ---- | -3,416.75%-21.21M | ---- | -18.18%-12.38M | ---- | ---603K | ---- | -23.40%-10.47M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | -73.96%400K | ---- | 7.35%5.26M | ---- | -26.40%1.54M | ---- | -49.54%4.9M | ---- | -76.28%2.09M |
| Impairment and provisions: | ---- | -100.75%-5K | ---- | 497.01%1.6M | ---- | 2,187.50%668K | ---- | 168.00%268K | ---- | -137.65%-32K |
| -Impairmen of inventory (reversal) | ---- | --141K | ---- | --105K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -121.86%-146K | ---- | 457.84%1.5M | ---- | 2,187.50%668K | ---- | 168.00%268K | ---- | -137.65%-32K |
| Revaluation surplus: | ---- | -121.25%-4.94M | ---- | -43.55%30.46M | ---- | 50.85%23.26M | ---- | 642.18%53.96M | ---- | 80.55%15.42M |
| -Other fair value changes | ---- | -121.25%-4.94M | ---- | -43.55%30.46M | ---- | 50.85%23.26M | ---- | 642.18%53.96M | ---- | 80.55%15.42M |
| Asset sale loss (gain): | ---- | -135.71%-5K | ---- | -30.00%14K | ---- | --14K | ---- | --20K | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -135.71%-5K | ---- | -30.00%14K | ---- | --14K | ---- | --20K | ---- | ---- |
| Depreciation and amortization: | ---- | 16.38%58.95M | ---- | 14.73%106.26M | ---- | 12.62%50.65M | ---- | 35.40%92.62M | ---- | 61.65%44.98M |
| -Amortization of intangible assets | ---- | -16.42%4.67M | ---- | -5.80%9.9M | ---- | 15.11%5.58M | ---- | -8.76%10.51M | ---- | -14.88%4.85M |
| Financial expense | ---- | 160.11%27.22M | ---- | -3.65%33.79M | ---- | -48.56%10.47M | ---- | 105.74%35.07M | ---- | 1,356.34%20.35M |
| Exchange Loss (gain) | ---- | -135.07%-11.58M | ---- | -50.31%43.65M | ---- | -81.52%33.01M | ---- | -69.77%87.84M | ---- | 11.63%178.64M |
| Special items | ---- | 9,306.61%32.04M | ---- | -116.58%-10.79M | ---- | -100.77%-348K | ---- | -49.69%65.1M | ---- | -31.68%44.92M |
| Adjustment items | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 95.21%-11.69M | ---- | 15.95%-426.32M | ---- | -12.57%-243.84M | ---- | 4.99%-507.23M | ---- | 7.17%-216.6M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -274.20%-17.09M | ---- | 212.23%47.65M | ---- | 125.97%9.81M | ---- | 18.53%-42.46M | ---- | -320.98%-37.77M |
| Accounts receivable (increase)decrease | ---- | -263.20%-42.09M | ---- | 74.43%-46.05M | ---- | 131.68%25.79M | ---- | -117.88%-180.08M | ---- | -202.51%-81.41M |
| Accounts payable increase (decrease) | ---- | 178.05%22.39M | ---- | 262.77%11.35M | ---- | -31.49%-28.69M | ---- | -110.05%-6.97M | ---- | -45.39%-21.82M |
| prepayments (increase)decrease | ---- | 53.25%-29.07M | ---- | -268.40%-17.63M | ---- | -1,180.80%-62.17M | ---- | -413.41%-4.79M | ---- | 66.23%-4.85M |
| Special items for working capital changes | ---- | 15.39%-5.71M | ---- | -39.68%-13.39M | ---- | -47.46%-6.75M | ---- | -9.59%-9.59M | ---- | 36.18%-4.58M |
| Cash from business operations | ---- | 72.78%-83.25M | ---- | 40.84%-444.38M | ---- | 16.67%-305.85M | ---- | -23.34%-751.11M | ---- | -20.04%-367.03M |
| Other taxs | ---- | ---129K | ---- | -132.26%-144K | ---- | ---- | ---- | ---62K | ---- | ---- |
| Interest received - operating | ---- | -7.52%21.57M | ---- | -1.08%78.97M | ---- | -54.75%23.32M | ---- | 83.93%79.84M | ---- | 38.52%51.54M |
| Special items of business | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---- |
| Adjustment items of business operations | 74.68%-84.34M | ---- | 167.26%56.52M | --1K | 25.33%-333.14M | ---- | 45.71%-84.04M | ---- | -12.86%-446.14M | ---- |
| Net cash from operations | 74.68%-84.34M | 78.12%-61.82M | 167.26%56.52M | 45.55%-365.55M | 25.33%-333.14M | 10.45%-282.53M | 45.71%-84.04M | -18.70%-671.34M | -12.86%-446.14M | -17.48%-315.49M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -26.35%76.95M | ---- | -42.86%16.05M | ---- | 33.25%104.47M | ---- | 93.48%28.1M | ---- | 12.88%78.41M | ---- |
| Decrease in deposits (increase) | ---- | 121.25%32.07M | ---- | 30.05%1.19B | ---- | -108.86%-150.92M | ---- | 164.82%914.56M | ---- | 261.95%1.7B |
| Sale of fixed assets | 995.97%5.12K | --5K | ---- | ---- | -85.54%467.52 | ---- | ---- | --12K | --3.23K | --3K |
| Purchase of fixed assets | 45.99%-38.49M | 54.79%-24.93M | 42.11%-15.06M | 69.55%-77.51M | 59.54%-71.27M | 51.15%-55.14M | 39.82%-26.01M | -12.02%-254.54M | 46.38%-176.13M | 20.07%-112.87M |
| Purchase of intangible assets | ---- | ---- | ---- | -545.95%-717K | ---- | ---- | ---- | 99.92%-111K | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.15M | ---- | ---- |
| Recovery of cash from investments | 79.88%8.17B | -37.51%55.16M | 37.98%1.4B | ---- | -1.38%4.54B | 149.29%88.27M | -0.66%1.02B | ---- | 6,043.77%4.61B | 8.96%35.41M |
| Cash on investment | -165.16%-8.53B | ---- | -157.10%-1.32B | ---- | -12.56%-3.22B | ---- | 48.27%-515M | ---- | -86.39%-2.86B | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -92.20%5.85M | ---- | -92.20%5.85M |
| Net cash from investment operations | -123.66%-321.5M | 152.89%62.3M | -84.44%78.22M | 66.61%1.11B | -17.68%1.36B | -107.22%-117.79M | 26,344.06%502.67M | 138.63%666.91M | 196.09%1.65B | 234.08%1.63B |
| Net cash before financing | -139.56%-405.84M | 100.12%480K | -67.81%134.75M | 16,945.30%745.57M | -14.85%1.03B | -130.43%-400.32M | 367.12%418.63M | 99.81%-4.43M | 157.01%1.2B | 188.59%1.32B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -75.71%258.77M | 724.16%83.24M | 1,064.71%79.2M | 3,406.87%1.19B | 3,816.54%1.07B | -20.47%10.1M | --6.8M | -89.60%33.8M | -91.63%27.2M | -96.09%12.7M |
| Refund | 82.41%-168.42M | -326.99%-117.42M | ---110.92M | -38,300.00%-960M | ---957.5M | ---27.5M | ---- | ---2.5M | ---- | ---- |
| Issuing shares | ---- | 100.40%16.12M | ---- | 85.99%18.5M | ---- | 42.99%8.04M | ---- | -99.66%9.95M | ---- | 622.08%5.63M |
| Interest paid - financing | ---- | -954.76%-17.49M | ---- | -31,562.88%-365.07M | ---- | -17.42%-1.66M | ---- | 64.66%-1.15M | ---- | -11.27%-1.41M |
| Dividends paid - financing | 93.07%-24.56M | ---- | -2,743.15%-8.18M | ---- | -16,916.24%-354.61M | ---- | 71.52%-287.53K | ---- | 8.29%-2.08M | ---- |
| Absorb investment income | 1.45%18.16M | ---- | -57.69%303.96K | ---- | 83.40%17.9M | ---- | -17.30%718.36K | ---- | -99.65%9.76M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | 42.35%-5.91M | ---- | -8.48%-13.35M | ---- | -70.67%-10.26M | ---- | 90.43%-12.31M | ---- | -7.17%-6.01M |
| Other items of the financing business | 265.48%54.26M | --86.42M | 593.12%72.35M | ---122.73M | -21.23%-32.79M | ---- | -82.83%-14.67M | ---- | -342.08%-27.05M | ---- |
| Net cash from financing operations | 152.81%138.21M | 186.99%28.33M | 540.22%32.75M | -21,934.48%-285.6M | -3,441.30%-261.69M | -2,682.71%-32.57M | 8.88%-7.44M | -99.96%1.31M | -99.75%7.83M | -99.59%1.26M |
| Effect of rate | -72.76%-29.43M | -325.23%-7.49M | -219.47%-3.26M | -34.14%16.93M | -135.72%-17.03M | -93.96%3.33M | 112.80%2.73M | -81.63%25.7M | -74.12%47.69M | -35.46%55.04M |
| Net Cash | -135.02%-267.63M | 106.66%28.81M | -59.26%167.5M | 14,852.34%459.98M | -36.98%764.11M | -132.87%-432.89M | 349.38%411.19M | -100.39%-3.12M | 22.15%1.21B | 211.59%1.32B |
| Begining period cash | 11.35%4.68B | 11.35%4.68B | 11.35%4.68B | 0.54%4.2B | 0.54%4.2B | 0.54%4.2B | 0.54%4.2B | 29.11%4.18B | 29.11%4.18B | 29.11%4.18B |
| Cash at the end | -11.46%4.38B | 24.59%4.7B | 4.92%4.84B | 11.35%4.68B | -9.02%4.95B | -32.04%3.77B | 15.59%4.62B | 0.54%4.2B | 23.24%5.44B | 159.12%5.55B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.